mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.04 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.04 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.087 |
0.04 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |